Business

GSK shares drift despite drug approvals boost

Daily Mail Money · 25 August 2026 at 08:06

GSK shares drift despite drug approvals boost

Drugs giant GSK saw its shares drift lower despite announcing progress on two key products yesterday.

Read the full article on Daily Mail Money ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.dailymail.co.uk — the content belongs to Daily Mail Money.

GSK shares drift despite drug approvals boost

More from Daily Mail Money

Bitcoin hits three-month high and gold price rises as investors back away from US assets

Energy bills will remain 'stubbornly high' until the end of the decade, major supplier warns

Are YOU letting your bank get rich off your cash? Savers urged to ditch poor-paying accounts: SIMON LAMBERT

MAGGIE PAGANO: When business veterans are worried about the state of Britain, it's time to reach for the crash helmets

More in Business

Bitcoin hits three-month high and gold price rises as investors back away from US assets

Energy bills will remain 'stubbornly high' until the end of the decade, major supplier warns

Gold hits highest level in three months as traders worry about US inflation and bond market jitters – business live

From Scotland, I look at England’s water privatisation disaster. I wish you had done what we did | Devi Sridhar

Are YOU letting your bank get rich off your cash? Savers urged to ditch poor-paying accounts: SIMON LAMBERT

Iran says it is 'fully prepared' to counter widened US economic sanctions